pembrolizumab,enfortumab vedotin,bempegaldesleukin,Nivolumab
astellas,seagen,merck,Nektar,BMS
['ev 302', 'muc ,(-much)', 'rcc,(-irccs),(-srcc),(-urcc)', ' ev ']
challenging the first line landscape in muc and mrcc
excellent discussion by eagerly waiting for ev 302 results! #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni